Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD

Introduction: Chronic inflammation is the core mechanism of the development of chronic obstructive pulmonary disease (COPD). Corticosteroid resistance in COPD limits its anti-inflammatory potency. p38 MAPKIs were suggested as an alternative to corticosteroids despite the fact that there is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Haichuan, Su, Xiaojie, Lei, Ting, Zhang, Lu, Feng, Zhouzhou, Zhang, Chuchu, Zhang, Meng, Wang, Yalei, Chen, Xinlong, Liu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554617/
https://www.ncbi.nlm.nih.gov/pubmed/36249771
http://dx.doi.org/10.3389/fphar.2022.950035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554617/
https://www.ncbi.nlm.nih.gov/pubmed/36249771
http://dx.doi.org/10.3389/fphar.2022.950035

Ejemplares similares